Evolus medical aesthetics focused on providing physicians and their patients with expanded choices in aesthetic procedures and treatments.
Evolus has raised $150.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in May 2025.
Evolus's investors include Oxford Finance LLC, Pharmakon Advisors.
Evolus is headquartered in Irvine, United States.
Evolus medical aesthetics focused on providing physicians and their patients with expanded choices in aesthetic procedures and treatments.
Evolus is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Evolus — Funding & Investors." VCBacked, May 5, 2025, https://www.vcbacked.co/company/evolus. Accessed August 14, 2026.
VCBacked. (2025). Evolus — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/evolus
{{cite web |title=Evolus — Funding & Investors |url=https://www.vcbacked.co/company/evolus |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated